News 20 Feb 2026 DNDi welcomes GHIT support for lead identification of a novel chemical series in the Eisai-led Chagas disease project
Press releases 10 Feb 2026 DNDi and Dubai Health launch Middle East partnership to advance research and training in neglected diseases
Scientific articles 9 Feb 2026 Repurposing oxfendazole for onchocerciasis: Population pharmacokinetics of a tablet formulation in healthy African adults CPT: Pharmacometrics & Systems Pharmacology
Scientific articles 3 Feb 2026 Evaluation of quality of care in Chagas disease cardiomyopathy Global Heart
News 2 Feb 2026 Message on the passing of Professor Sir Nicholas White from DNDi Board Chair Dr Marie-Paule Kieny and DNDi Executive Director Dr Luis Pizarro
News 30 Jan 2026 Imperial and DNDi strengthen partnership to accelerate treatments for neglected diseases
In the media 30 Jan 2026 Why India still carries the heaviest burden of neglected tropical diseases Nature India
Scientific articles 9 Feb 2026 Repurposing oxfendazole for onchocerciasis: Population pharmacokinetics of a tablet formulation in healthy African adults CPT: Pharmacometrics & Systems Pharmacology
Scientific articles 3 Feb 2026 Evaluation of quality of care in Chagas disease cardiomyopathy Global Heart
Scientific articles 22 Jan 2026 Analysis of the consultations on the InfoChagas digital platform PLOS Neglected Tropical Diseases
Scientific articles 14 Jan 2026 Determinants of long-term SARS-CoV-2 immune responses in asymptomatic-to-moderate COVID-19 patients in sub-Saharan Africa BMC Medicine
Scientific articles 12 Jan 2026 Dengue therapeutics consortium 2025: a global collaboration in action BMJ Global Health
Scientific articles 10 Jan 2026 Liposomal antimicrobials in the fight against bacterial and fungal pathogens: Clinical successes and development challenges International Journal of Pharmaceutics X
Scientific articles 9 Jan 2026 Skin pharmacokinetics and pharmacodynamics in patients with post-kala-azar dermal leishmaniasis International Journal of Antimicrobial Agents
Scientific articles 9 Jan 2026 Target product profile for the development of pediatric formulations of new drugs for the treatment of children with T. cruzi infection PLOS Neglected Tropical Diseases
Scientific articles 9 Jan 2026 Global health is in crisis: to reach neglected patients, we need to reimagine medical research BMJ Global Health
Scientific articles 17 Dec 2025 Kronopolitides A–F, a family of 36-membered polyol macrolides with antiparasitic activity against Chagas disease Journal of Natural Products
Scientific articles 2 Dec 2025 The development of a global research agenda and individual participant data platform for visceral leishmaniasis: challenges and future opportunities Parasites & Vectors
Scientific articles 25 Nov 2025 Bidirectional interaction between liposomal amphotericin B pharmacokinetics and parasite dynamics in patients with post-kala-azar dermal leishmaniasis: Potential implications for optimal dosing Clinical Pharmacology & Therapeutics
Scientific articles 20 Nov 2025 Safety, tolerability and pharmacokinetics of DNDI-6148, a novel agent for leishmaniasis: A randomized, controlled, single ascending dose study in healthy participants British Journal of Clinical Pharmacology
Scientific articles 4 Nov 2025 Host-derived molecules as novel chagas disease biomarkers: hypercoagulability markers and extracellular vesicles Methods in Molecular Biology
Scientific articles 30 Oct 2025 Target product profile and discovery and development path for novel cryptococcal disease treatments Journal of Infection
